Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eli Lilly

757.39
+25.603.50%
Post-market: 748.37-9.0200-1.19%19:59 EDT
Volume:4.65M
Turnover:3.49B
Market Cap:717.81B
PE:64.68
High:758.87
Open:740.00
Low:738.00
Close:731.79
Loading ...

Eli Lilly slams PBS as Trump says pharma tariffs not far off

The Australian Financial Review
·
15 Apr

US Begins Probes into Pharmaceutical, Chip Imports, Setting Stage for Tariffs

Reuters
·
15 Apr

Eli Lilly's Mounjaro launch in India ignites wave of weight-loss enquiries

Reuters
·
15 Apr

Eli Lilly (LLY) Stock Jumps as Rival Pfizer Drops Out of Race to Develop Weight Loss Pill

TIPRANKS
·
15 Apr

Pharmaceutical Stocks Trim Their Gains. Trump Says Pharmaceutical Tariffs in Not Too Distant Future

Tiger Newspress
·
15 Apr

Pfizer just had a big setback in its race for an Ozempic competitor

Quartz
·
14 Apr

Eli Lilly Is Maintained at Buy by Guggenheim

Dow Jones
·
14 Apr

Pfizer discontinues GLP-1 pill trial, stock trades flat

Yahoo Finance
·
14 Apr

Obesity Drugmakers Shares Rise After Pfizer Ends Development of Weight-Loss Pill Danuglipron

Reuters
·
14 Apr

Shares of Eli Lilly up 1.8%, Drug Developer Viking Therapeutics Shares Rise 13%

THOMSON REUTERS
·
14 Apr

Shares of U.S. Listed Obesity Drugmakers Rise After Pfizer to End Development of Its Experimental Weight-Loss Pill

THOMSON REUTERS
·
14 Apr

Wegovy, Zepbound makers' stocks rally as a weight-loss-drug competitor drops out

Dow Jones
·
14 Apr

Three Stocks That May Be Trading Below Their Estimated Value In April 2025

Simply Wall St.
·
14 Apr

Shares of Eli Lilly up 2%, Drug Developer Viking Therapeutics Shares Rise 16.5%

THOMSON REUTERS
·
14 Apr

Shares of U.S. Listed Obesity Drugmakers Rise Premarket After Pfizer to End Development of Its Experimental Weight-Loss Pill

THOMSON REUTERS
·
14 Apr

Affirm, Grab, Viking, Pfizer, Eli Lilly: Trending by Analysts

TIPRANKS
·
12 Apr

Why Eli Lilly and Company (LLY) Is the Best Medical Stock to Buy According to Billionaires

Insider Monkey
·
12 Apr

Eli Lilly Drops $1.57B Bombshell--And Wall Street Shrugs It Off

GuruFocus.com
·
11 Apr

Wall Street Pulls Back on the Weight-Loss Drug Hype -- Barrons.com

Dow Jones
·
11 Apr

Top Research Reports for Eli Lilly, American Express & Thermo Fisher

Zacks
·
11 Apr